Subscribe free

Newsletter

Sarcoma & rare tumors

Every new paper in this field, in your inbox.

FreeNo spamOne-click unsubscribe
J Formos Med Assoc6 Apr 2024

Improved Survival with Sequential Multimodal Therapy for Soft Tissue Sarcoma

Patients with advanced soft tissue sarcoma who receive sequential multimodal treatments with chemotherapy and surgery have better overall survival compared to those who only receive chemotherapy. Surgery appears to be more beneficial for patients who undergo chemotherapy first. These findings support the use of a…

J Gastrointest Surg5 Apr 2024

Impact of Preoperative Anemia on Outcomes in GEP-NET Resections

Patients with preoperative anemia undergoing curative-intent resection for gastroenteropancreatic neuroendocrine tumors (GEP-NETs) had higher rates of major complications and poorer long-term outcomes. Anemia was associated with worse overall survival, while postoperative transfusions were linked to lower overall survival and recurrence-free survival rates. Preoperative anemia affected…

Surg Endosc3 Apr 2024

Frequency of size increase in gastric leiomyomas is low

Most gastric leiomyomas are benign subepithelial tumors, with few becoming symptomatic or increasing in size. A retrospective review of 231 cases showed that only 2.4% experienced size increase, one of which was leiomyosarcoma. The majority remained stable, with resections confirming leiomyoma. Close monitoring may be…

World J Surg27 Mar 2024

Prognostic Factors for Liver Metastasis in Small Intestinal Stromal Tumors

Researchers analyzed data from 1582 patients with small intestinal stromal tumors to identify risk factors for liver metastasis. They found that poor tumor grade, absence of surgery, later T-stage, and no chemotherapy were associated with an increased risk of liver metastasis. A nomogram prediction model…

Dis Colon Rectum17 Mar 2024

Radical resection favored for grade 2 rectal neuroendocrine tumors >1.5 cm

Comparing local excision and radical resection for grade 2 rectal neuroendocrine tumors showed no significant difference in survival for tumors ≤1.5 cm. However, tumors >1.5 cm had significantly lower relapse-free survival with local excision. Lymph node metastasis was present in 60% of patients who underwent…

BMC Surg9 Mar 2024

Improvement in Clinical Outcomes and Diagnostic Accuracy with Multidisciplinary Management of Retroperitoneal Liposarcoma

Multidisciplinary team management in retroperitoneal liposarcoma treatment led to higher overall survival rates at 1, 3, and 5 years, improved diagnostic consistency, reduced perioperative mortality and postoperative complications, and enhanced disease awareness and postoperative compliance. The intervention showed significant benefits in clinical outcomes and diagnostic…